Randomised Study of Ethyl-Eicosapentaenoic Acid versus Placebo as Supplemenal Treatment in Schizophrenia.

Simple item page
dc.contributor.authorEmsley RA
dc.contributor.authorMyburgh C
dc.contributor.authorOosthuizen P
dc.contributor.authorVan Rensburg SJ
dc.date.accessioned2013-01-23T13:46:25Z
dc.date.available2013-01-23T13:46:25Z
dc.date.issued2003
dc.descriptionGesondheidswetenskappe
dc.descriptionPsigiatrie
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.identifier.citationAmerican Journal of Psychiatry
dc.identifier.urihttp://hdl.handle.net/10019.1/76475
dc.publisherAMER PSYCHIATRIC PRESS, INC, 1000 WILSON BOULEVARD, STE 1825, ARLINGTON, USA,VA, 22209-3901
dc.titleRandomised Study of Ethyl-Eicosapentaenoic Acid versus Placebo as Supplemenal Treatment in Schizophrenia.
dc.typeJournal Articles (subsidised)
Files
Collections
2003 - Research Outputs